ReachRxResearch
Home
Research
Sign Up
External validation of the prognostic performance of a heart failure-specific skeletal muscle mass equation: insights from the J-Proof HF registry
Back to Research Hub
  1. Home
  2. Research Hub
  3. External validation of the prognostic pe…

External validation of the prognostic performance of a heart failure-specific skeletal muscle mass equation: insights from the J-Proof HF registry

Nutrition, Metabolism and Cardiovascular Diseases·October 3
Endocrinology & MetabolismConfirms priorHeart FailureProspective Registry Study / External ValidationPrognostic Equation / Skeletal Muscle Mass AssessmentAdult

Summary

View source

What was studied

External validation of a heart failure (HF)-specific skeletal muscle mass equation for predicting prognosis in patients with HF, using data from the J-Proof HF registry.

Key findings

The HF-specific skeletal muscle mass equation demonstrated prognostic performance in the J-Proof HF registry, supporting its validity as a tool for risk stratification in HF patients, though specific numeric outcomes (e.g., hazard ratios, AUC values) were not available in the provided source text.

Study limitations

External validation was conducted in a single registry (J-Proof HF), which may limit generalizability; the registry is Japanese, potentially restricting applicability to other ethnic groups; reliance on an equation-based estimate of skeletal muscle mass rather than direct measurement introduces inherent measurement error.

Clinical implications

Clinicians managing heart failure patients may use this HF-specific skeletal muscle mass equation as a prognostic tool to identify high-risk patients, though validation across more diverse populations is still needed.

Caveats

  • Skeletal muscle mass is estimated via an equation rather than directly measured (e.g., by DEXA or MRI), which introduces potential measurement imprecision
  • The full text of this paper was not available; structured data were extracted from the title, abstract, and DOI only, which limits the specificity of numeric results and may affect accuracy of extracted details
  • The study population is drawn from a Japanese registry (J-Proof HF), which may limit generalizability to non-Asian populations

Related Questions

Explore related topics

How is skeletal muscle mass measured and used for prognosis in heart failure patients?What is the J-Proof HF registry and what outcomes does it track?How does sarcopenia affect outcomes in patients with heart failure?

Publication Details

Year
2026
Journal
Nutrition, Metabolism and Cardiovascular Diseases
Source
View article
Keep scrolling
More content below.
Up Next